DK1501859T3 - 17 alpha-fluoroalkyl-11 beta-benzaldoxime steroids, process for their preparation, pharmaceutical compositions containing these steroids and their use in the manufacture of drugs - Google Patents
17 alpha-fluoroalkyl-11 beta-benzaldoxime steroids, process for their preparation, pharmaceutical compositions containing these steroids and their use in the manufacture of drugsInfo
- Publication number
- DK1501859T3 DK1501859T3 DK03725149T DK03725149T DK1501859T3 DK 1501859 T3 DK1501859 T3 DK 1501859T3 DK 03725149 T DK03725149 T DK 03725149T DK 03725149 T DK03725149 T DK 03725149T DK 1501859 T3 DK1501859 T3 DK 1501859T3
- Authority
- DK
- Denmark
- Prior art keywords
- steroids
- fluoroalkyl
- drugs
- beta
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Abstract
The invention relates to compounds of general formula I and the pharmaceutically compatible salts thereof, wherein R1 represents hydrogen, C1- to C6-alkyl, COR4, COOR4, COSR4 or CONHR5, wherein R4 represents C1- to C6-alkyl or unsubstituted or substituted aryl and R5 represents hydrogen, C1- to C6-alkyl or unsubstituted or substituted aryl, additionally R2 represents hydrogen, C1- to C6-alkyl or C1- to C6-acyl and R3 represents a CnF2n+1-group, wherein n = 1, 2 or 3, or represents a CH2O(CH2)mCnF2n+1-group, whereby m = 0 or 1 and n = 1, 2 or 3. The invention also relates to a method for producing said compounds of general formula I. Said compounds can be used in the production of medicaments.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10221034A DE10221034A1 (en) | 2002-05-03 | 2002-05-03 | New 17-alpha-fluoroalkyl-11-beta-benzaldoxime-estradiene derivatives, useful as antigestagens in post-menopausal hormone replacement therapy or for treating e.g. gynecological disorders |
US44940103P | 2003-02-25 | 2003-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1501859T3 true DK1501859T3 (en) | 2006-03-06 |
Family
ID=29403591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03725149T DK1501859T3 (en) | 2002-05-03 | 2003-05-05 | 17 alpha-fluoroalkyl-11 beta-benzaldoxime steroids, process for their preparation, pharmaceutical compositions containing these steroids and their use in the manufacture of drugs |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1501859B1 (en) |
JP (1) | JP2005536463A (en) |
AT (1) | ATE307823T1 (en) |
AU (1) | AU2003227717A1 (en) |
DE (1) | DE50301507D1 (en) |
DK (1) | DK1501859T3 (en) |
ES (1) | ES2252670T3 (en) |
WO (1) | WO2003093292A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006054535A1 (en) | 2006-11-15 | 2008-05-21 | Bayer Schering Pharma Aktiengesellschaft | Progesterone receptor antagonist |
DE102009034368A1 (en) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-acyloxyalkylenephenyl derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034362A1 (en) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034366A1 (en) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-methyleneoxyalkylene aryl derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034367A1 (en) * | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-benzylidene derivatives, process for their preparation and their use for the treatment of diseases |
DE102009034525A1 (en) | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases |
DE102010007719A1 (en) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesterone receptor antagonist |
DE102010007722A1 (en) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesterone receptor antagonist |
US20130029953A1 (en) * | 2011-07-28 | 2013-01-31 | Klaus Nickisch | Progesterone antagonists |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19706061A1 (en) * | 1997-02-07 | 1998-08-13 | Schering Ag | Anti-gestagen effective steroids with fluorinated 17alpha alkyl chain |
DE19745085A1 (en) * | 1997-10-11 | 1999-04-15 | Jenapharm Gmbh | 11β-Benzaldoxim-9alpha, 10alpha-epoxy-estr-4-ene derivatives, processes for their preparation and pharmaceutical preparations containing these compounds |
-
2003
- 2003-05-05 EP EP03725149A patent/EP1501859B1/en not_active Expired - Lifetime
- 2003-05-05 ES ES03725149T patent/ES2252670T3/en not_active Expired - Lifetime
- 2003-05-05 JP JP2004501431A patent/JP2005536463A/en active Pending
- 2003-05-05 AU AU2003227717A patent/AU2003227717A1/en not_active Abandoned
- 2003-05-05 WO PCT/EP2003/004686 patent/WO2003093292A1/en active IP Right Grant
- 2003-05-05 DE DE50301507T patent/DE50301507D1/en not_active Expired - Fee Related
- 2003-05-05 AT AT03725149T patent/ATE307823T1/en not_active IP Right Cessation
- 2003-05-05 DK DK03725149T patent/DK1501859T3/en active
Also Published As
Publication number | Publication date |
---|---|
DE50301507D1 (en) | 2005-12-01 |
EP1501859B1 (en) | 2005-10-26 |
AU2003227717A1 (en) | 2003-11-17 |
WO2003093292A1 (en) | 2003-11-13 |
JP2005536463A (en) | 2005-12-02 |
ES2252670T3 (en) | 2006-05-16 |
ATE307823T1 (en) | 2005-11-15 |
EP1501859A1 (en) | 2005-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0204235A2 (en) | Substituted glutarimides and use thereof il-12 production inhibitors, process for their preparation and pharmaceutical compositions containing them | |
HUP9802323A2 (en) | Pyrimidine derivatives , process for producing them and pharmaceutical compositions containing them | |
HUP0302167A2 (en) | Quinoline derivatives as metabotropic glutamate receptor antagonists, pharmaceutical compositions containing them and process for producing them | |
SE0102438D0 (en) | New compounds | |
HUP0302474A2 (en) | Therapeutically effective tropane derivatives, process for their preparation pharmaceutical compositions containing them and their use | |
HUP0401982A2 (en) | Indolizine derivates, process for their preparation and pharmaceutical compositions containing the compounds | |
DE50304569D1 (en) | XANTHENCARBONIC ACID ESTERS OF TROPENOL AND SCOPINS AS M3 ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DRUGS | |
HUP0002104A2 (en) | Pyrazolo[3,4-d]pyrimidinedione derivatives, process for their preparation and pharmaceutical compositions containing them | |
ATE361924T1 (en) | DIHYDROPTERIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT | |
NO20054763L (en) | Salts of clopidogrel and process for their preparation | |
HUP0102084A2 (en) | Quinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
PA8539501A1 (en) | TRIAZOLO COMPOUNDS AS MMP INHIBITORS | |
DE60202958D1 (en) | STABLE POLYMORPH OF FLIBANSERIN, INDUSTRIAL PROCESS FOR THE PRODUCTION THEREOF AND ITS USE FOR THE PRODUCTION OF MEDICAMENTS | |
EA200501268A1 (en) | HIV-Inhibiting 1,2,4-TRIAZINS | |
HUP9701265A2 (en) | Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
ATE289996T1 (en) | ARYLGLYCINAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
DK1501859T3 (en) | 17 alpha-fluoroalkyl-11 beta-benzaldoxime steroids, process for their preparation, pharmaceutical compositions containing these steroids and their use in the manufacture of drugs | |
BR0008206A (en) | Epothilon derivatives, processes for their preparation and pharmaceutical application | |
HUP0204354A2 (en) | Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same and their use | |
EA200300044A1 (en) | NEW SUBSTITUTED PHTHALIDES, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS | |
DE59909917D1 (en) | DIPHENYL-SUBSTITUTED 5-RING HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT | |
ATE400552T1 (en) | 4,4'-DITHIOBIS-(3-AMINOBUTANE-1-SULFONATE) DERIVATIVES AND COMPOSITIONS CONTAINING THEM | |
ATE297918T1 (en) | TETRAHYDROPYRIDINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
HUP9802731A2 (en) | Vitamin d analogues, use thereof, medicaments containing them, their production | |
SG146627A1 (en) | Imidazole derivatives |